BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29942314)

  • 1. Ectonucleotidase-Mediated Suppression of Lupus Autoimmunity and Vascular Dysfunction.
    Knight JS; Mazza LF; Yalavarthi S; Sule G; Ali RA; Hodgin JB; Kanthi Y; Pinsky DJ
    Front Immunol; 2018; 9():1322. PubMed ID: 29942314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crowding within synaptic junctions influences the degradation of nucleotides by CD39 and CD73 ectonucleotidases.
    Rahmaninejad H; Pace T; Chun BJ; Kekenes-Huskey PM
    Biophys J; 2022 Jan; 121(2):309-318. PubMed ID: 34922916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of purinergic signaling on renal ischemia-reperfusion injury.
    Lu B; Rajakumar SV; Robson SC; Lee EK; Crikis S; d'Apice AJ; Cowan PJ; Dwyer KM
    Transplantation; 2008 Dec; 86(12):1707-12. PubMed ID: 19104409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses.
    Shevchenko I; Mathes A; Groth C; Karakhanova S; Müller V; Utikal J; Werner J; Bazhin AV; Umansky V
    Oncoimmunology; 2020 Apr; 9(1):1744946. PubMed ID: 33457090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Ectonucleotidases Signal Impaired Myocardial Perfusion at Rest and Stress.
    Kroll RG; Powell C; Chen J; Snider NT; St Hilaire C; Reddy A; Kim J; Pinsky DJ; Murthy VL; Sutton NR
    J Am Heart Assoc; 2023 May; 12(9):e027920. PubMed ID: 37119076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host CD39 Deficiency Affects Radiation-Induced Tumor Growth Delay and Aggravates Radiation-Induced Normal Tissue Toxicity.
    Meyer AV; Klein D; de Leve S; Szymonowicz K; Stuschke M; Robson SC; Jendrossek V; Wirsdörfer F
    Front Oncol; 2020; 10():554883. PubMed ID: 33194619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury.
    Bönner F; Borg N; Burghoff S; Schrader J
    PLoS One; 2012; 7(4):e34730. PubMed ID: 22514659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
    Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
    FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A
    Kelestemur T; Németh ZH; Pacher P; Beesley J; Robson SC; Eltzschig HK; Haskó G
    Respir Res; 2023 Jul; 24(1):186. PubMed ID: 37438813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
    Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
    Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury.
    Rajakumar SV; Lu B; Crikis S; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM
    Transplantation; 2010 Dec; 90(12):1260-4. PubMed ID: 21063242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
    Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
    Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
    Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
    J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD39 abrogates platelet-derived factors induced IL-1β expression in the human placenta.
    Forstner D; Guettler J; Brugger BA; Lyssy F; Neuper L; Daxboeck C; Cvirn G; Fuchs J; Kraeker K; Frolova A; Valdes DS; Stern C; Hirschmugl B; Fluhr H; Wadsack C; Huppertz B; Nonn O; Herse F; Gauster M
    Front Cell Dev Biol; 2023; 11():1183793. PubMed ID: 37325567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
    Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
    Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways.
    Giatromanolaki A; Kouroupi M; Pouliliou S; Mitrakas A; Hasan F; Pappa A; Koukourakis MI
    Life Sci; 2020 Oct; 259():118389. PubMed ID: 32898522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer.
    Li J; Wang L; Chen X; Li L; Li Y; Ping Y; Huang L; Yue D; Zhang Z; Wang F; Li F; Yang L; Huang J; Yang S; Li H; Zhao X; Dong W; Yan Y; Zhao S; Huang B; Zhang B; Zhang Y
    Oncoimmunology; 2017; 6(6):e1320011. PubMed ID: 28680754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD73 Ectonucleotidase Restrains CD8+ T Cell Metabolic Fitness and Anti-tumoral Activity.
    Briceño P; Rivas-Yañez E; Rosemblatt MV; Parra-Tello B; Farías P; Vargas L; Simon V; Cárdenas C; Lladser A; Salazar-Onfray F; Elorza AA; Rosemblatt M; Bono MR; Sauma D
    Front Cell Dev Biol; 2021; 9():638037. PubMed ID: 33681221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation.
    Roberts V; Stagg J; Dwyer KM
    Front Immunol; 2014; 5():64. PubMed ID: 24600452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.